Fujian Cosunter Pharmaceutical Co Ltd Sustainability Reports

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. Its portfolio primarily focuses on anti-hepatitis B virus (HBV) therapies, liver health treatments, respiratory, cardiovascular, and men's health medications.

Sector: Manufacturing

Country: China

Exchange: Shenzhen Stock Exchange

FIGI: BBG006DB5NF5

2 reports from 2021 to 2025

• Fujian Cosunter Pharmaceutical Co Ltd 2025 Annual Social Responsibility Report
• Fujian Cosunter Pharmaceutical Co Ltd 2021 Annual Report Summary